查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1578381

心臟节律器市场：全球产业分析、规模、占有率、成长、趋势、预测，2024-2033年

Cardiac Pacemaker Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 163 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research对心臟起搏器市场进行了全面分析，深入了解其复杂的动态和未来轨迹。本报告深入探讨了市场趋势、成长催化剂、障碍和新兴模式，并提供了2024-2033年有价值的统计资料和预测。

主要见解

  • 市场规模（2024年）：39.238亿美元
  • 市场预测金额（2033年）：54.01亿美元
  • 世界成长率（CAGR2024年～2033年）：3.6%

调查范围：

心臟节律器市场包括用于调节心律不整患者心律的植入式心律调节器和体外心律调节器。这些设备在治疗心搏过缓、心臟衰竭和心房颤动等心臟疾病方面发挥重要作用。心律调节器是一种救生医疗设备，可透过电脉衝帮助维持规律的心跳。该市场服务于医院、门诊手术中心和心臟专科中心，重点关注先进的微创手术和长期设备有效性。

推动市场成长的因素：

全球心臟节律器市场由几个关键因素驱动。人口老化和心血管疾病盛行率的增加是市场需求的主要驱动力。久坐生活方式的增加以及肥胖和糖尿病等相关风险因素导致心臟相关疾病激增，进一步推动市场成长。此外，心律调节器技术的不断进步，包括无线、无引线心律调节器和 MRI 相容设备，改善患者的治疗效果并提高采用率。随着先进医疗保健的普及，医疗保健支出的增加（尤其是在新兴国家）也推动了市场成长。

市场抑制要因：

儘管成长前景广阔，但心臟节律器市场仍面临阻碍扩张的挑战。先进起搏器设备和外科手术的高成本限制了医疗基础设施低度开发地区的市场渗透率。此外，对潜在设备故障和导线移位和感染等併发症的担忧也导致患者和医生犹豫不决。新起搏器型号所需的严格监管批准进一步减缓了新进入者的创新和市场进入。

市场机会：

心臟节律器市场存在多个有利的成长机会。技术进步，特别是无线心律调节器和无引线心律调节器的进步，为创新和市场成长开闢了新的途径。这些发展最大限度地减少了患者的不适，并降低了与传统起搏器相关的併发症的风险。此外，对远端监测解决方案不断成长的需求推动人工智慧（AI）和物联网（IoT）技术整合到心律调节器设备中，使医疗保健提供者能够即时监测患者的心臟健康状况。亚太地区和拉丁美洲的新兴市场拥有快速发展的医疗基础设施，随着心血管治疗机会的改善，具有巨大的成长潜力。

关键问题

  • 推动心臟节律器市场全球成长的关键因素是什么？
  • 技术进步如何影响新起搏器型号的开发？
  • 市场参与者面临哪些主要挑战以及如何应对这些挑战？
  • 哪些人口统计和地区对于起搏器提供者而言最具成长潜力？
  • 领先的公司采取哪些策略来使心律调节器在竞争格局中脱颖而出？

目次

第1章 执行摘要

第2章 市场介绍

  • 市场定义
  • 市场分类

第3章 全球心臟节律器市场分析场景

  • 市场规模（百万美元）和预测
  • 市场概要

第4章 市场动态

  • 宏观经济因素
  • 促进要因
    • 供给侧
    • 需要侧
  • 抑制要因
  • 机会
  • 偿付和监管情景

第5章 全球心臟节律器市场分析与预测：依产品

  • 简介
  • 基点占有率（BPS）分析：依产品类型
  • 年成长预测：依产品类型分类
  • 市场价值预测：依产品分类，2024-2033年
    • 植入式心臟节律器
      • 单腔起搏器
      • 双腔心律调节器
      • 双心室节律器
    • 体外心臟节律器
  • 市场吸引力：依产品分类

第6章 全球心臟节律器市场分析与预测：依最终用户

  • 简介
  • 基点占有率（BPS）分析：依最终用户分类
  • 年成长预测：依最终用户
  • 2024-2033年市场价值预测：依最终用户
    • 病院
    • 门诊手术中心
  • 市场吸引力：依最终用户

第7章 全球心臟节律器市场分析与预测：依地区

  • 基点占有率（BPS）分析：依地区
  • 年成长预测：依地区
  • 市场价值预测：依地区
    • 北美
    • 拉丁美洲
    • 欧洲
    • 亚太地区
    • 中东、非洲
  • 市场吸引力：依地区

第8章 北美心臟节律器市场分析与预测

第9章 拉丁美洲心臟节律器市场分析与预测

第10章 欧洲心臟节律器市场分析及预测

第11章 亚太心臟节律器市场分析与预测

  • 简介
    • 基点占有率（BPS）分析：依国家分类
    • 年成长预测：依国家划分
  • 市场价值预测：依产品分类，2024-2033年
    • 植入式心臟节律器
      • 单腔起搏器
      • 双腔心律调节器
      • 双心室节律器
    • 体外心臟节律器
  • 市场价值预测：依最终用户划分，2024-2033年
    • 病院
    • 门诊手术中心
  • 市场价值预测：依国家划分，2024-2033年
    • 中国
    • 印度
    • 日本
    • 澳洲/纽西兰
    • 亚太地区其他国家
  • 市场吸引力分析
  • 显着趋势

第12章 中东与非洲心臟节律器市场分析与预测

第13章 竞争情势

  • 竞争仪表板
  • 公司简介（详细资料 - 概述、财务状况、策略、近期发展）
    • BIOTRONIK SE &Co. KG
    • Boston Scientific Corporation
    • Medtronic
    • St. Jude Medical Inc.
    • LivaNova PLC.
    • lepumedical.com
    • Osypka Medical GmbH
    • Pacetronix.com
    • MEDICOWEB

第14章 使用的先决条件与缩写

第15章 研究方法

简介目录
Product Code: PMRREP12382

Persistence Market Research offers a comprehensive analysis of the Cardiac Pacemaker Market, providing insights into its complex dynamics and future trajectory. This report delves into market trends, growth catalysts, obstacles, and emerging patterns, presenting valuable statistics and projections from 2024 to 2033.

Key Insights:

  • Market Size (2024): USD 3923.8 Mn
  • Projected Market Value (2033): USD 5401 Mn
  • Global Growth Rate (CAGR 2024-2033): 3.6%

Report Scope:

The Cardiac Pacemaker Market comprises implantable and external pacemakers used to regulate heart rhythm in patients with arrhythmias. These devices play a critical role in the treatment of heart conditions such as bradycardia, heart failure, and atrial fibrillation. Pacemakers are life-saving medical devices that help in maintaining a regular heartbeat through electrical pulses. The market serves hospitals, ambulatory surgical centers, and specialized cardiac care centers, with a growing focus on advanced, minimally invasive procedures and long-lasting device efficacy.

Market Growth Drivers:

The global Cardiac Pacemaker Market is driven by several key factors. An aging population with an increasing prevalence of cardiovascular diseases is a major driver of market demand. The rise in sedentary lifestyles and associated risk factors, such as obesity and diabetes, has led to a surge in heart-related conditions, further fueling market growth. Moreover, continuous advancements in pacemaker technology-such as wireless, leadless pacemakers and MRI-compatible devices-enhance patient outcomes and drive adoption rates. Increasing healthcare spending, particularly in emerging economies, also supports market growth, as access to advanced medical treatments becomes more widespread.

Market Restraints:

Despite promising growth prospects, the Cardiac Pacemaker Market faces challenges that could hinder its expansion. High costs associated with advanced pacemaker devices and surgical procedures limit market penetration in regions with underdeveloped healthcare infrastructure. Additionally, concerns about potential device malfunctions and complications, such as lead displacement or infections, create hesitation among patients and physicians. Stringent regulatory approvals required for new pacemaker models further slow down innovation and market entry for new players.

Market Opportunities:

The Cardiac Pacemaker Market presents several lucrative growth opportunities. Technological advancements, particularly in wireless and leadless pacemakers, open up new avenues for innovation and market growth. These developments minimize patient discomfort and reduce the risk of complications associated with traditional pacemakers. Additionally, increasing demand for remote monitoring solutions provides opportunities for market players to integrate artificial intelligence (AI) and Internet of Things (IoT) technologies into pacemaker devices, allowing healthcare providers to monitor patients' heart health in real time. Emerging markets in Asia-Pacific and Latin America, where healthcare infrastructure is rapidly evolving, offer significant growth potential as access to cardiovascular treatments improves.

Key Questions Answered:

  • What are the primary factors driving the growth of the Cardiac Pacemaker Market globally?
  • How are technological advancements influencing the development of new pacemaker models?
  • What are the key challenges facing market participants, and how can they be addressed?
  • Which demographic groups and geographic regions present the highest growth potential for pacemaker providers?
  • What strategies are leading companies employing to differentiate their pacemaker offerings in the competitive medical device landscape?

Competitive Intelligence and Business Strategy:

Leading players in the Cardiac Pacemaker Market, including pacemaker manufacturers and healthcare providers, focus on product innovation, safety enhancements, and geographic expansion to gain a competitive edge. Companies invest heavily in research and development to create next-generation pacemakers that are smaller, more efficient, and compatible with advanced diagnostic tools such as MRI. Strategic partnerships with hospitals, academic institutions, and technology firms enable market players to accelerate innovation, streamline regulatory processes, and expand their presence in key regions.

Emphasis on after-sales services, including patient monitoring, product recalls, and technical support, further enhances brand reputation and fosters long-term relationships with healthcare providers and patients. Continuous improvements in product durability, battery life, and patient safety are central to market players' strategies as they seek to maintain competitive advantage.

Key Companies Profiled:

  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Medtronic
  • St. Jude Medical Inc.
  • LivaNova PLC.
  • lepumedical.com
  • Osypka Medical GmbH
  • Pacetronix.com
  • MEDICOWEB
  • Others.

Market Segmentation:

By Type:

  • Implantable Pacemakers
  • External Pacemakers

By Product:

  • Single-Chamber Pacemakers
  • Dual-Chamber Pacemakers
  • Biventricular Pacemakers

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Care Centers

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa

Table of Contents

1. Executive Summary

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Global Cardiac Pacemaker Market Analysis Scenario

  • 3.1. Market Size (US$ Mn) and Forecast
  • 3.2. Market Overview

4. Market Dynamics

  • 4.1. Macro-economic Factors
  • 4.2. Drivers
    • 4.2.1. Supply Side
    • 4.2.2. Demand Side
  • 4.3. Restraints
  • 4.4. Opportunity
  • 4.5. Reimbursement and Regulatory Scenario

5. Global Cardiac Pacemaker Market Analysis and Forecasts, By Product

  • 5.1. Introduction
  • 5.2. Basis Point Share (BPS) Analysis By Product Type
  • 5.3. Y-o-Y Growth Projections By Product Type
  • 5.4. Market Value Forecast By Product, 2024-2033
    • 5.4.1. Implantable Cardiac Pacemaker
      • 5.4.1.1. Single Chamber Pacemaker
      • 5.4.1.2. Dual Chamber Pacemaker
      • 5.4.1.3. Biventricular Pacemaker
    • 5.4.2. External Cardiac Pacemaker
  • 5.5. Market Attractiveness By Product

6. Global Cardiac Pacemaker Market Analysis and Forecasts, By End User

  • 6.1. Introduction
  • 6.2. Basis Point Share (BPS) Analysis By End User
  • 6.3. Y-o-Y Growth Projections By End User
  • 6.4. Market Value Forecast By End User, 2024-2033
    • 6.4.1. Hospitals
    • 6.4.2. Ambulatory Surgical Centers
  • 6.5. Market Attractiveness By End User

7. Global Cardiac Pacemaker Market Analysis and Forecasts, By Region

  • 7.1. Basis Point Share (BPS) Analysis By Region
  • 7.2. Y-o-Y Growth Projections By Region
  • 7.3. Market Value Forecast By Region
    • 7.3.1. North America
    • 7.3.2. Latin America
    • 7.3.3. Europe
    • 7.3.4. APAC
    • 7.3.5. MEA
  • 7.4. Market Attractiveness By Region

8. North America Cardiac Pacemaker Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Basis Point Share (BPS) Analysis By Country
    • 8.1.2. Y-o-Y Growth Projections By Country
  • 8.2. Market Value Forecast By Product, 2024-2033
    • 8.2.1. Implantable Cardiac Pacemaker
      • 8.2.1.1. Single Chamber Pacemaker
      • 8.2.1.2. Dual Chamber Pacemaker
      • 8.2.1.3. Biventricular Pacemaker
    • 8.2.2. External Cardiac Pacemaker
  • 8.3. Market Value Forecast By End User, 2024-2033
    • 8.3.1. Hospitals
    • 8.3.2. Ambulatory Surgical Centers
  • 8.4. Market Value Forecast By Country, 2024-2033
    • 8.4.1. US
    • 8.4.2. Canada
  • 8.5. Market Attractiveness Analysis
    • 8.5.1. By Product
    • 8.5.2. By End User
    • 8.5.3. By Country
  • 8.6. Prominent Trends

9. Latin America Cardiac Pacemaker Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Basis Point Share (BPS) Analysis By Country
    • 9.1.2. Y-o-Y Growth Projections By Country
  • 9.2. Market Value Forecast By Product, 2024-2033
    • 9.2.1. Implantable Cardiac Pacemaker
      • 9.2.1.1. Single Chamber Pacemaker
      • 9.2.1.2. Dual Chamber Pacemaker
      • 9.2.1.3. Biventricular Pacemaker
    • 9.2.2. External Cardiac Pacemaker
  • 9.3. Market Value Forecast By End User, 2024-2033
    • 9.3.1. Hospitals
    • 9.3.2. Ambulatory Surgical Centers
  • 9.4. Market Value Forecast By Country, 2024-2033
    • 9.4.1. Argentina
    • 9.4.2. Brazil
    • 9.4.3. Mexico
    • 9.4.4. Rest of Latin America
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product
    • 9.5.2. By End User
    • 9.5.3. By Country
  • 9.6. Prominent Trends

10. Europe Cardiac Pacemaker Market Analysis and Forecast

  • 10.1.Introduction
    • 10.1.1. Basis Point Share (BPS) Analysis By Country
    • 10.1.2. Y-o-Y Growth Projections By Country
  • 10.2.Market Value Forecast By Product, 2024-2033
    • 10.2.1. Implantable Cardiac Pacemaker
      • 10.2.1.1. Single Chamber Pacemaker
      • 10.2.1.2. Dual Chamber Pacemaker
      • 10.2.1.3. Biventricular Pacemaker
    • 10.2.2. External Cardiac Pacemaker
  • 10.3.Market Value Forecast By End User, 2024-2033
    • 10.3.1. Hospitals
    • 10.3.2. Ambulatory Surgical Centers
  • 10.4.Market Value Forecast By Country, 2024-2033
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Poland
    • 10.4.7. Russia
    • 10.4.8. Rest Of Europe
  • 10.5.Market Attractiveness Analysis
    • 10.5.1. By Product
    • 10.5.2. By End User
    • 10.5.3. By Country
  • 10.6. Prominent Trends

11. APAC Cardiac Pacemaker Market Analysis and Forecast

  • 11.1.Introduction
    • 11.1.1. Basis Point Share (BPS) Analysis By Country
    • 11.1.2. Y-o-Y Growth Projections By Country
  • 11.2.Market Value Forecast By Product, 2024-2033
    • 11.2.1. Implantable Cardiac Pacemaker
      • 11.2.1.1. Single Chamber Pacemaker
      • 11.2.1.2. Dual Chamber Pacemaker
      • 11.2.1.3. Biventricular Pacemaker
    • 11.2.2. External Cardiac Pacemaker
  • 11.3.Market Value Forecast By End User, 2024-2033
    • 11.3.1. Hospitals
    • 11.3.2. Ambulatory Surgical Centers
  • 11.4.Market Value Forecast By Country, 2024-2033
    • 11.4.1. China
    • 11.4.2. India
    • 11.4.3. Japan
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest OF APAC
  • 11.5.Market Attractiveness Analysis
    • 11.5.1. By Product
    • 11.5.2. By End User
    • 11.5.3. By Country
  • 11.6. Prominent Trends

12. MEA Cardiac Pacemaker Market Analysis and Forecast

  • 12.1.Introduction
    • 12.1.1. Basis Point Share (BPS) Analysis By Country
    • 12.1.2. Y-o-Y Growth Projections By Country
  • 12.2.Market Value Forecast By Product, 2024-2033
    • 12.2.1. Implantable Cardiac Pacemaker
      • 12.2.1.1. Single Chamber Pacemaker
      • 12.2.1.2. Dual Chamber Pacemaker
      • 12.2.1.3. Biventricular Pacemaker
    • 12.2.2. External Cardiac Pacemaker
  • 12.3.Market Value Forecast By End User, 2024-2033
    • 12.3.1. Hospitals
    • 12.3.2. Ambulatory Surgical Centers
  • 12.4.Market Value Forecast By Country, 2024-2033
    • 12.4.1. GCC Countries
    • 12.4.2. South Africa
    • 12.4.3. Rest of MEA
  • 12.5.Market Attractiveness Analysis
    • 12.5.1. By Product
    • 12.5.2. By End User
    • 12.5.3. By Country
  • 12.6. Prominent Trends

13. Competition Landscape

  • 13.1. Competition Dashboard
  • 13.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.2.1. BIOTRONIK SE & Co. KG
    • 13.2.2. Boston Scientific Corporation
    • 13.2.3. Medtronic
    • 13.2.4. St. Jude Medical Inc.
    • 13.2.5. LivaNova PLC.
    • 13.2.6. lepumedical.com
    • 13.2.7. Osypka Medical GmbH
    • 13.3.8. Pacetronix.com
    • 13.3.9. MEDICOWEB

14. Assumptions and Acronyms Used

15. Research Methodology